Taken together, our results demonstrate that RKIP-regulated NPC cell radioresponse is mediated through ERK and AKT signaling, and RKIP reduction promotes NPC cell radioresistance by increasing ERK and AKT activity. This evidence concerns the gene MAPK1 and nasopharyngeal carcinoma.